Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Synthesis of Phosphatidylcholine in the ER Membrane

Synthesis of Phosphatidylcholine in the ER Membrane

The ER synthesizes lipids for building cell membranes and performing cellular functions such as energy storage and signaling. The lipid synthesis machinery embedded in the ER membrane primarily collects all reactants from the cytosol. Following synthesis, the secretory pathway and the ER contact sites distribute these lipids to other cellular organelles. Additionally, the energy-rich triacylglycerides are transported from the ER via lipid droplets.
The major components of all eukaryotic cell...

Mucosal Barrier of the Stomach

Mucosal Barrier of the Stomach

The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...

Surface Membrane Barriers

Surface Membrane Barriers

The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining. Bicarbonate,...

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...

Membrane Lipids

Membrane Lipids

Lipids are an essential component of all biological membranes. The average lipid content in mammalian membranes is 50%, though it can be as low as 20% in the inner mitochondrial membrane or as high as 80% in the myelin sheath present around the nerve cells.
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Optimizing recruitment in rare disease research: a cross-sectional online study evaluating sampling strategies for hard-to-reach populations.

Orphanet journal of rare diseases·2026

Same author

<sup>68</sup>Ga-FAPI PET/CT for non-invasive characterization and activity assessment of ulcerative colitis and Crohn´s disease.

European journal of nuclear medicine and molecular imaging·2026

Same author

The role of copper dysregulation in Wilson disease: an expert opinion.

Frontiers in medicine·2025

Same author

Diabetes-preventive molecular mechanisms of breast versus formula feeding: new insights into the impact of milk on stem cell Wnt signaling.

Frontiers in nutrition·2025

Same author

Peer Support in Chronic Conditions from the Peer Supporters' Perspective: A Systematic Review.

Psychosocial intervention·2025

Same author

Drug Repurposing to Inhibit Oncostatin M in Crohn's Disease.

Molecules (Basel, Switzerland)·2025

Search research articles

Related Experiment Video

Updated: May 15, 2026

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Published on: September 12, 2025

Mucosal protection by phosphatidylcholine.

Wolfgang Stremmel¹, Robert Ehehalt, Sabine Staffer

¹Department of Gastroenterology, University Hospital Heidelberg, Heidelberg, Germany. wolfgang_stremmel @ med.uni-heidelberg.de

Digestive Diseases (Basel, Switzerland)

|January 9, 2013

Summary

Phosphatidylcholine (PC) in colonic mucus acts as a barrier against bacteria. Supplementing PC in ulcerative colitis (UC) patients reduced inflammation, suggesting PC

More Related Videos

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA₂

Published on: September 26, 2025

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

Published on: July 27, 2017

Related Experiment Videos

Last Updated: May 15, 2026

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Three-dimensional Quantification of Intestinal Mucus Using Whole-mount Tissue Imaging

Published on: September 12, 2025

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA2

A Liposome Membrane Permeability Assay for Investigating the Effects of Phosphatidylinositol Phosphate Groups on Membranotropic Action of Venom PLA₂

Published on: September 26, 2025

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

PIP-on-a-chip: A Label-free Study of Protein-phosphoinositide Interactions

Published on: July 27, 2017

Area of Science:

Gastroenterology
Mucosal Immunology
Molecular Gastronomy

Background:

Colonic mucus, primarily composed of phosphatidylcholine (PC), forms a crucial barrier against commensal bacteria and prevents inflammation.
PC is arranged in lamellar structures, creating a hydrophobic surface that deters bacterial invasion into the hydrated mucus gel.
Reduced mucus PC content (by 70%) in ulcerative colitis (UC) may represent a primary pathogenetic factor predisposing to inflammation.

Purpose of the Study:

To investigate the role of phosphatidylcholine (PC) in colonic mucus barrier function.
To explore the potential of PC supplementation as a therapeutic strategy for ulcerative colitis (UC).

Main Methods:

Analysis of colonic mucus composition, specifically PC content.
Clinical trials involving oral, delayed-release PC supplementation in UC patients.

Main Results:

Ulcerative colitis (UC) is characterized by a significant reduction in mucus phosphatidylcholine (PC) content.
Oral delayed-release PC supplementation led to improvement and resolution of inflammation in UC patients over a 3-month treatment period.
PC distribution in the colon, thinning towards the rectum, correlates with the typical rectal onset of UC symptoms.

Conclusions:

Mucus phosphatidylcholine (PC) plays an essential protective role in the colon against inflammation.
PC supplementation is a promising therapeutic approach for managing ulcerative colitis (UC) by restoring the mucus barrier.
The findings highlight the importance of mucus composition in maintaining intestinal homeostasis and preventing inflammatory conditions.